Table 1.
Interpretation
|
Test
|
Site (s)
|
Function
|
Hepatocellular integrity | ALT | Hepatocyte (main), cardiac, renal and muscle tissue to smaller extent | Amino acid catabolism. Glutamate and pyruvate production for ATP production |
AST | Hepatocyte, cardiac, muscle and brain tissue | ||
LDH | Nonspecific, present widely in the body | Anaerobic glycolysis major enzyme in addition to NADH production. Significant in ischemic hepatitis | |
Cholestatic pattern | ALP | Hepatobiliary tract, bone, placenta and intestines | Dephosphorylation reactions. Role in bile production |
GGT | Mainly in hepatobiliary tract, present in multiple other organs (nonspecific as an isolate test) | Aids in identification of elevated ALP of biliary origin | |
5’nucleotidase | Nonspecific, present widely in the body | Clinical value in hepatobiliary and cholestatic disease specifically when paired with ALP and GGT | |
Bilirubin | Serum and liver | End product of heme breakdown. Exists in conjugated and unconjugated form. Elevation in conjugated suggestive of possible cholestasis | |
Synthetic function | Albumin | Serum | Main protein in the serum, maintains oncotic pressure. Produced by the liver |
PT/INR | Test to measure extrinsic coagulation pathway | Clotting factors primarily produced in the liver. Helpful however does not reflect true coagulation status |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; LDH: Lactate dehydrogenase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase; ATP: Adenosine-triphosphate; PT: Prothrombin time; INR: International normalized ratio.